After disappointing trial results led to canceled orders, an encouraging new study may give Merck’s anti-Covid pill a new boost.
Subscribe to:
Post Comments (Atom)
< + > Hybrid Intelligence with Carta Healthcare – Life Sciences Today Podcast Episode 33
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Aaron Brauser, Ge...
-
As I’m sure you know, times are tough. Wages have largely remained the same while prices have risen across the board – and healthcare is no ...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
The following is a guest article by Ladd Wiley, Senior Vice President for Global Corporate Affairs, Public Policy, and Advocacy at Epic , ...
No comments:
Post a Comment